O’ZBEKISTON RESPUBLIKASIDA RO’YXATGA OLINGAN METABOLIK TA’SIRGA EGA DORI VOSITALARINING MARKETING TAHLILI
Article Sidebar
Main Article Content
Аннотация:
Ushbu maqola O’zbekiston Respublikasida tibbiyot amaliyotida qo’llanilishiga ruxsat etilgan metabolik ta’sirga ega dori vositalarining retrospektiv marketing tahlilini o’z ichiga oladi. Tahlil assortiment, geografik taqsimot, ATC klassifikatsiyasi va dori shakllari yo’nalishlari bo’yicha amalga oshirildi. Natijalar reestrda metabolik dori vositalarining salmiqli o’rin egallashini, ularda xorijiy ishlab chiqaruvchilar ustunligini, L-karnitin guruhining boshqa ATC guruhlariga nisbatan hukmron mavqeini hamda parenteral shakllarning enteral shakllardan ustunligini ko’rsatdi. Olingan ma’lumotlar milliy dori ta’minoti siyosatini takomillashtirish va mahalliy farmatsevtika ishlab chiqarishini kengaytirish bo’yicha amaliy tavsiyalar uchun ilmiy asos bo’lib xizmat qiladi.
Article Details
Как цитировать:
Библиографические ссылки:
World Health Organization. (2023). Noncommunicable diseases: Key facts. WHO. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
International Diabetes Federation. (2021). IDF Diabetes Atlas (10th ed.). IDF. https://www.diabetesatlas.org
Timmis, A., Vardas, P., Townsend, N., Torbica, A., Katus, H., De Smedt, D., ... & Vardas, P. (2022). European Society of Cardiology: Cardiovascular disease statistics 2021. European Heart Journal, 43(8), 716–799. https://doi.org/10.1093/eurheartj/ehab892
O’zbekiston Respublikasi Davlat statistika qo’mitasi. (2023). O’zbekiston aholisining sog’lig’i va demografik ko’rsatkichlari 2022. Davlat statistika qo’mitasi.
WHO Collaborating Centre for Drug Statistics Methodology. (2023). ATC/DDD Index 2023. Norwegian Institute of Public Health. https://www.whocc.no/atc_ddd_index/
Shu, Y., Liu, Y., Li, L., Xu, L., & Long, L. (2022). Effectiveness of L-carnitine supplementation for the management of type 2 diabetes: A systematic review and meta-analysis. Nutrients, 14(13), Article 2758. https://doi.org/10.3390/nu14132758
Nemchenko, A. S., & Nemchenko, O. A. (2018). Metodicheskie podkhody k marketingovomu analizu farmatsevticheskogo rynka [Methodological approaches to pharmaceutical market marketing analysis]. Klinichna Farmatsiia, 22(2), 4–10. https://doi.org/10.24959/cphj.18.1457
Egamov, J. S., & Yusupova, S. A. (2021). O’zbekiston farmasevtika bozorining tahliliy ko’rsatkichlari [Analytical indicators of the Uzbekistan pharmaceutical market]. Farmatsiya va Farmakologiya, (3), 18–25.
O’zbekiston Respublikasi Sog’liqni saqlash vazirligi, & DUK “Dori vositalari, tibbiy buyumlar va tibbiy texnika ekspertizasi va standartlashtirish Davlat markazi”. (2023). Tibbiyot amaliyotida qo’llanilishiga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika Davlat reestri: 27-nashr (2023 yil yanvar holatiga ko’ra). DUK DSTM.
World Health Organization. (1993). How to investigate drug use in health facilities: Selected drug use indicators (WHO/DAP/93.1). WHO.